Quarter-by-quarter earnings deep dives: execution vs promises, earnings quality, cash conversion and management credibility.
Indian pharma experiencing bifurcation - diversified players (Lupin, Cipla) thriving; single-product-dependent players (Natco with Revlimid) struggling.
Navin Fluorine delivered its strongest quarterly performance with record revenues and industry-leading 32.5% operating margins, driven by all three business segments firing simultaneously while announcing strategic capacity expansions worth ₹311.5 crores to capture growing opportunities in…
TCS delivered operationally sound execution with margin expansion despite wage hikes, but announced a transformational strategic shift toward becoming "the world's largest AI-led technology services company" backed by a ₹6-7 billion AI datacenter investment, marking a departure from its…
Extracting alpha from quarterly results. In your inbox, free.
